“We are very excited to collaborate with Thermo Fisher and leverage the capabilities of the Genexus system,” said Marcia Eisenberg, Ph.D., chief scientific officer of LabCorp Diagnostics. “This ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Molecular profiling is key in precision oncology research and whilst the tissue testing has become a routine, liquid biopsy might provide a non-invasive alternative when tissue biopsy is inaccessible.

IRVINE, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing clear insights that ...

With traditional NGS, long turnaround times (TAT) of 4+ weeks and high failure rates due to quantity not sufficient (QNS) are common. The Ion Torrent™ Genexus™ System is a better testing solution: it ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific today launched the CE-IVD marked Ion Torrent Genexus Dx Integrated Sequencer, an automated, next-generation sequencing (NGS) platform that ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Thermo Fisher Scientific has announced the launch of its Ion Torrent Genexus System, a fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report workflow ...

LabCorp announced it will adopt the Ion Torrent Genexus System and Oncomine Precision Assay for use in research and development of companion diagnostics as well as other future oncology and precision ...

Fortis Memorial Research Institute (FMRI), Gurugram, in collaboration with Agilus Diagnostics has launched its second Genexus system, further strengthening India’s fastest and most scalable rapid ...

BURLINGTON, N.C. & CARLSBAD, Calif.--(BUSINESS WIRE)--LabCorp® (NYSE: LH) announced it will adopt the Ion Torrent Genexus System* and Oncomine Precision Assay* for use in research and development of ...